Pharmaceutical combination comprising nucleotide and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/24 (2006.01) A61K 31/496 (2006.01) A61K 31/536 (2006.01) A61K 31/5513 (2006.01) A61K 31/7068 (2006.01) A61K 31/7072 (2006.01) A61K 31/7076 (2006.01) A61K 45/06 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2633603

A pharmaceutical formulation for the treatment of HIV is provided. The formulation is a combination of a nucleoside reverse transcriptase inhibitor and a nucleotide reverse transcriptase inhibitor in which the combination has an increased stability over prior, art combination therapies. The invention also provides a pharmaceutical product containing the formulation.

La présente invention concerne une formulation pharmaceutique pour le traitement du VIH. La formulation est une combinaison d'un inhibiteur de transcriptase inverse de nucléoside et d'un inhibiteur de transcriptase inverse de nucléotide caractérisée en ce que la combinaison a une stabilité augmentée par rapport à des thérapies de combinaison de l'art antérieur. L'invention concerne en outre un produit pharmaceutique contenant la formulation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical combination comprising nucleotide and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical combination comprising nucleotide and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical combination comprising nucleotide and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1772776

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.